Principal Consultant / Founder
CurrentSUMMARY: Demonstrated success in defining and implementing global regulatory CMC strategies to advance biological products including orphan products from preclinical studies to global marketing approvals (e.g. US, EU, Japan, Canada, Australia, etc.). Two decades of industry experience across multiple disciplines (immunology, oncology, hematology.